Evidence map›Paper›PMID 25748686›Full record

ArticleLeukemia2015

Efficacy and toxicity of dexamethasone vs methylprednisolone-long-term results in more than 1000 patients from the Russian randomized multicentric trial ALL-MB 2002.

A Karachunskiy, J Roumiantseva, S Lagoiko, C Bührer, G Tallen, O Aleinikova, O Bydanov, N Korepanova, L Bajdun, T Nasedkina and 17 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

A KarachunskiyFederal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
J RoumiantsevaFederal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
S LagoikoFederal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
C BührerDepartment of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
G TallenDepartment of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
O AleinikovaRepublic Clinical Research Centre for Pediatric Oncology and Hematology, Minsk, Belarus.
O BydanovRepublic Clinical Research Centre for Pediatric Oncology and Hematology, Minsk, Belarus.
N KorepanovaFederal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
L BajdunFederal Central Russian Children Hospital, Moscow, Russia.
T NasedkinaFederal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
A von StackelbergDepartment of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
G NovichkovaFederal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
A MaschanFederal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
D LitvinovFederal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
N MyakovaFederal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
N PonomarevaFederal Central Russian Children Hospital, Moscow, Russia.
K KondratchikDepartment of Oncology, Hematology and radiotherapy, Pirogov Russian National Research Medical University, Moscow, Russia.
L FechinaPaediatric Oncohematological Centre, Regional Children's Hospital, Ekaterinburg, Russia.
O StrenevaPaediatric Oncohematological Centre, Regional Children's Hospital, Ekaterinburg, Russia.
N JudinaDepartment of Pediatric Oncology/Hematology, Regional Children's Hospital, Voronezh, Russia.
G ScharapovaDepartment of Pediatric Oncology/Hematology, Regional Children's Hospital, Nizhnevartovsk, Russia.
A ShamardinaDepartment of Pediatric Hematology, Regional Children's Hospital, Nizhni Novgorod, Russia.
I GerbekDepartment of Pediatric Oncology/Hematology, Regional Children's Hospital, Tomsk, Russia.
A ShapochnikDepartment of Pediatric Oncology/Hematology, Regional Oncological Hospital, Orenburg, Russia.
A RumjanzewFederal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
G HenzeFederal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
ALL-MB study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsDexamethasoneHumansMethylprednisoloneMulticenter Studies as TopicPrecursor Cell Lymphoblastic Leukemia-LymphomaRandomized Controlled Trials as TopicRussiaTime FactorsDexamethasoneMethylprednisolone

Identifiers

PMID25748686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.